---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-400087"
form_type: "8-K"
ticker: "JAGX"
cik: "0001585608"
company_name: "Jaguar Health, Inc."
filed_at: "2026-09-24T10:01:32+00:00"
generated_at: "2026-09-24T10:05:13.127353+00:00"
event_type: "debt"
sentiment: "negative"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Jaguar Health issues 547,898 shares to cut $5.05M of 2025 Streeterville note

## Summary
- Exchanged 547,898 common shares for $5,049,909 reduction in $10.81M secured note to Streeterville Capital.
- Shares issued under Section 3(a)(9); no cash paid, shares to become free-trading after Rule 144 holding period tacking.
- Post-exchange share count ~1,281,867; issuance adds ~74.6% to prior outstanding stock.
- Note reduction represents ~47% of original principal; remaining balance continues under existing terms.
- CEO Lisa Conte signed; Streeterville receives unrestricted shares via DWAC delivery.

## SEC filing metadata
- accession: 0001193125-26-400087
- form_type: 8-K
- ticker: JAGX
- cik: 0001585608
- company_name: Jaguar Health, Inc.
- filed_at: 2026-09-24T10:01:32+00:00
- event_type: debt
- sentiment: negative
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 1.01, 3.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1585608/000119312526400087/0001193125-26-400087-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1585608/000119312526400087/d161376d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-400087
- JSON: https://secwatch.observer/filing/0001193125-26-400087.json
- Plain text: https://secwatch.observer/filing/0001193125-26-400087.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.